Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the fatty sheath that covers nerve cells in the brain and spinal cord.

Sphingosine is a membrane component in all cells and constitutes 25% of the lipid in the myelin sheath. Sphingosine is phosphorylated by ubiquitously expressed sphingosine kinases. S1P regulates ...

They will receive ascending doses of Lucid-MS or a placebo for multiple ... in multiple sclerosis.” MS is caused by the immune system mistakenly attacking the myelin sheath, a protective coating ...

Good news for those suffering from multiple sclerosis: a new class of drugs for the treatment of the disease is in advanced ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

A new technology is designed to be a “wearable” device for neurons, wrapping around individual nerve fibers with a goal of achieving new ways to study and treat neurological diseases like ...

A 2017 clinical trial found that minocycline lowered the risk of conversion to multiple sclerosis after someone has their first demyelinating event, also known as clinically isolated syndrome.

MS is an inflammatory autoimmune disease marked by extensive damage to the insulating myelin sheath that protects ... Life pressure can increase the risk of Multiple Sclerosis.

Sphingolipids are important components of the cell membrane, especially in the brain and the myelin sheath on neurons ... Alzheimer’s disease, and multiple sclerosis. Recent studies have ...